Norwegian-registered foreign company
AOP ORPHAN PHARMACEUTICALS SWEDEN AB NUF
ActiveMarket research and public opinion polling (73.200)
The life line 2024–2026
Operating revenue per year, with recorded events above. As a table
Operating revenue 2025: SEK 40.5m.
- Founded§ 16
Sources: the Register of Company Accounts (company accounts), fetched 8 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.
In brief
AOP ORPHAN PHARMACEUTICALS SWEDEN AB NUF is a norwegian-registered foreign company, in the industry market research and public opinion polling. The chief executive is Christian Anders Feinberg. In 2025 the company had SEK 40.5m in operating revenue and a net profit of SEK 2.1m.
Put together by Intelligo from the sections below; each figure stands with its source where it belongs.
Overview
§ 01 Latest changes
3 changes, latest 22 Jul 2026
- Annual accounts filed 2024 → 2025
- Godkjente årsregnskap
- Endring av daglig leder
Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 22 Nov 2026 · All events →
Overview
§ 02 Worth knowing
1 point
- OKEquity ratio 45.9%, above the industry median
Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate
Overview
§ 03 Key figures
Revenue SEK 40.5m in 2025
Revenue
SEK 40.5m
+29.2% from 2024
20232025
Operating profit
SEK 2.8m
+57.4% from 2024
20232025
Net profit
SEK 2.1m
+56.6% from 2024
20232025
Equity
SEK 6.0m
+53.0% from 2024
20232025
Source: the Register of Company Accounts, read 8 Nov 2026 · The full accounts →
Finances
§ 04 Where the money comes from and goes
Financial year 2025
Of every krone of operating revenue in 2025:
- Operating costs 93%
- Left as operating result 7%
Of the net profit for 2025, SEK 2.1m stayed in the company. The rest, SEK 38k, is an assumed dividend.
The assumed dividend is derived by Intelligo from the change in equity, not stated by the source. Source: the Register of Company Accounts, read 8 Nov 2026
Finances
§ 05 Financial health
Equity ratio 45.9%
- AOP ORPHAN PHARMACEUTICALS SWEDEN AB NUF, 2025
- Industry median, assumed: 3.4% · 28.2% · +2.9%
Equity SEK 6.0m46% of the assets (SEK 13.2m)
Source: the Register of Company Accounts, read 8 Nov 2026. The median is derived by Intelligo from 59 companies in 73.200 Market research and public opinion polling, not stated by the source.
Finances
§ 06 Accounts
2 years, latest 2025
| SEK 1,000 | 2024–25 | 2025 | 2024 |
|---|---|---|---|
| Operating revenue | 40,457 | 31,314 | |
| Operating profit | 2,818 | 1,790 | |
| Profit before tax | 2,821 | 1,793 | |
| Net profit | 2,128 | 1,359 | |
| Total assets | 13,160 | 8,461 | |
| Equity | 6,036 | 3,946 | |
| Liabilities | 7,124 | 4,515 |
Source: the Register of Company Accounts, read 8 Nov 2026 · All 2 years →
Management and ownership
§ 07 Officers
3 officers now
- VAAK REGNSKAP ASAccountant
- AOP ORPHAN PHARMACEUTICALS SWEDEN ABDetails of the company in its home country
- Christian Anders FeinbergChief executive since 2022
Source: the Brønnøysund Register Centre, read 12 Aug 2026 · All 3 roles, former ones too →
Management and ownership
§ 08 Signature, procuration and authorisations
None registered
No signature or procuration registered.The Register of Business Enterprises has no provision for the company. Checked 22 Nov 2026.
Management and ownership
§ 09 Owners
None registered
No owners registered.The Tax Administration's shareholder register covers limited companies and has no owners for this business. Checked 22 Nov 2026.
Management and ownership
§ 10 Group
None registered
Not a group.No subsidiaries in the shareholder register, and no group accounts. Checked 22 Nov 2026.
Management and ownership
§ 11 Portfolio
None registered
No holdings registered.The shareholder register has no shares held by the company. Checked 22 Nov 2026.
Management and ownership
§ 12 Network
1 connection
- Person
- Company
1 person links AOP ORPHAN PHARMACEUTICALS SWEDEN AB NUF to 1 other companies: Christian Anders Feinberg 1.
Source: the Brønnøysund Register Centre, read 12 Aug 2026 · Explore the network →
Events and registers
§ 13 Events
6 since 2022
Events per year
20222026
Since 2022: 5 announcements and 1 register change. Most happened in 2022 and 2023.
Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 18 Nov 2026. Register changes are Intelligo's own observations. · All 6 events →
Events and registers
§ 14 Notices
5, latest 14 Jul 2025
- Godkjente årsregnskap
- Godkjente årsregnskap
- Godkjente årsregnskap
Source: The Brønnøysund Register Centre's announcements ↗, read 18 Nov 2026 · All 5 →
Events and registers
§ 15 Charges
Not fetched yet
Events and registers
§ 16 Other registers
Found in 2 of 7
- The Central Coordinating RegisterRegistered 29 Jun 2019
- VATNot registered
- The Register of Business EnterprisesRegistered 29 Jun 2019
- The Cleaning RegisterNot registered
- The Register of Staffing AgenciesNot registered
- Smiley scheme, the Norwegian Food Safety AuthorityNot registered
- The Financial Supervisory Authority's licence registerNot registered
Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 22 Nov 2026
Market
§ 17 Tenders
None registered
No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 22 Nov 2026.
Market
§ 18 Vacancies
None registered
No vacancies.No open ads at NAV. Checked 22 Nov 2026.
Market
§ 19 Competitors
Industry code 73.200
The companies most like it:
Compare themThe selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 22 Nov 2026 · All competitors →
Last
§ 20 Questions and answers
3 questions
- Who is the chief executive of AOP ORPHAN PHARMACEUTICALS SWEDEN AB NUF?
Christian Anders Feinberg, since 2022. § 07 - What was the revenue in 2025?
SEK 40.5m in the company. § 06 - Where is AOP ORPHAN PHARMACEUTICALS SWEDEN AB NUF based?
Kista Science Tower, Färögatan 33, plan 31, Se-164 51 Kista.
The answers come from the sections linked to, with their sources.